Guna-Lumbar
Generic name: aluminum oxide, anti-interleukin-1.alpha. immunoglobulin g rabbit, canakinumab, metenkefalin, bryonia alba root, hamamelis virginiana root bark/stem bark, sus scrofa intervertebral disk, sodium sulfate, phosphoric acid and sepia officinalis juice
Dosage form: injection, solution
Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Drug Abuse and Dependence
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- References
- Patient Counseling Information
1. INDICATIONS AND USAGE
1.1 Lumbar pain due to degenerative lumbar spine disorders (lumbar and lumbar-sacral arthrosis)
1.2 Lumbar vertebral osteophytes
1.3 Low back pain due to muscular and tendinous trigger points. The simultaneous administration of GUNA®-MUSCLE gives wider therapeutic coverage.
1.4 Simple lumbar pain (low back syndrome)
1.5 Weak low back syndrome
1.6 Postural low back ache
1.7 Lumbar and lumbo-sacral mechanical imbalance
1.8 Lumbar and lumbo-sacral spinal malalignment syndrome
1.9 Sacro-iliac syndrome
1.10 Spinal Enthesopathy/Ligament Laxity
1.11 Spinal lumbar and lumbo-sacral nerve root pain. The simultaneous administration of GUNA®-NEURAL gives wider therapeutic coverage.
2. DOSAGE AND ADMINISTRATION
2.1. Standard protocol for IM administration: 1 vial 1-3 times a week according to severity and clinical progress.
2.2. Standard protocol according to mesotherapy technique using 1 vial per treatment: 2 treatments for the first 2 weeks, 1 treatment a week till pain relief (average 8-10 sessions). For chronic pathologies: continue 1 treatment a week for 1 month till pain relief, then 1 treatment a month.
Select application site according to trigger points, tender points, referred pain zones, acupuncture points, nerve key points, Head zones or “local pain points”. Using a 13 mm, 30G or a 4 mm, 27G needle, make the classic intradermal injection according to mesotherapy technique.
Discard unused solution.
2.3. Opening of Vials: Use sterile needles and sterile syringe. Do not reuse. Do not use if foreign particles are presen
